BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
Florham Park, NJ, June 17, 2025 – BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.
This News Release is only available in English.
